Compare ALGT & CLDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ALGT | CLDX |
|---|---|---|
| Founded | 1997 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Air Freight/Delivery Services | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.9B | 2.6B |
| IPO Year | 2006 | 1995 |
| Metric | ALGT | CLDX |
|---|---|---|
| Price | $98.48 | $37.52 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 10 | 10 |
| Target Price | ★ $97.30 | $46.60 |
| AVG Volume (30 Days) | 424.9K | ★ 908.5K |
| Earning Date | 04-30-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 81.62 | N/A |
| EPS | ★ 2.30 | N/A |
| Revenue | ★ $2,606,579,000.00 | $12,743,000.00 |
| Revenue This Year | $9.42 | $111.39 |
| Revenue Next Year | $6.52 | $235.85 |
| P/E Ratio | $42.94 | ★ N/A |
| Revenue Growth | 3.74 | ★ 87.78 |
| 52 Week Low | $43.03 | $19.72 |
| 52 Week High | $123.63 | $40.30 |
| Indicator | ALGT | CLDX |
|---|---|---|
| Relative Strength Index (RSI) | 46.25 | 60.21 |
| Support Level | $82.73 | $28.51 |
| Resistance Level | $108.60 | $40.30 |
| Average True Range (ATR) | 4.29 | 1.56 |
| MACD | -1.23 | -0.00 |
| Stochastic Oscillator | 40.35 | 78.27 |
Allegiant Travel Co is a leisure travel company focused on providing travel and leisure services and products to residents of underserved cities in the United States. It operates a low-cost, low utilization passenger airline marketed to leisure travelers in underserved cities, allowing it to sell air transportation both on a stand-alone basis and bundled with the sale of air-related and third-party services and products. In addition, it provides air transportation under fixed-fee flight arrangements. In connection with its leisure travel focus, the company has opened Sunseeker Resort Charlotte Harbor, equipped with several guestrooms and food and beverage outlets. The company's operating segments are the Airline, which generates the maximum revenue, and Sunseeker Resort.
Celldex Therapeutics Inc is a biopharmaceutical firm focused on mast cell biology and the development of therapeutic antibodies. Its pipeline includes monoclonal and bispecific antibodies aimed at treating severe inflammatory, allergic, autoimmune, and other mast cell-mediated diseases. The company operates in a single operating and reportable segment in the business of development, manufacturing and commercialization of novel therapeutics for human health care.